Podcasts about Biotechnology

AI accelerates drug discovery while steroids turn teens into aggressive strangers. Dr. Michael Israetel explores our pharmaceutical crossroads here!Full show notes and resources can be found here: jordanharbinger.com/1209What We Discuss with Michael Israetel:GLP-1 drugs like Tirzepatide offer massive health benefits beyond weight loss — reducing inflammation, improving brain health, and decreasing addiction behaviors, even for people already in good shape.Steroids don't just amplify personality — they specifically amplify masculine traits like aggression and reduce empathy. Starting young can permanently rewire your brain's emotional and social processing.AI is about to revolutionize medicine by testing millions of drug candidates virtually, creating treatments 10x more effective with 10x fewer side effects. We're entering the pharmaceutical iPhone moment.The "only take drugs when sick" mindset worked in the 20th century, but is becoming dangerously outdated — like refusing elevators because you prefer human operators.When your diet plateaus, take a week-long break eating at maintenance. Your stress hormones will drop, body water will flush out, and you'll often look leaner than before.And much more...And if you're still game to support us, please leave a review here — even one sentence helps! Sign up for Six-Minute Networking — our free networking and relationship development mini course — at jordanharbinger.com/course!Subscribe to our once-a-week Wee Bit Wiser newsletter today and start filling your Wednesdays with wisdom!Do you even Reddit, bro? Join us at r/JordanHarbinger!This Episode Is Brought To You By Our Fine Sponsors:Saily: 15% off: saily.com/jordanharbinger, code JORDANHARBINGERDripDrop: 20% off: DripDrop.com, code JORDANLinkedIn Jobs: Post your job for free: linkedin.com/jordanQuince: Free shipping & 365-day returns: quince.com/jordanBetterHelp: 10% off first month: betterhelp.com/jordanSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode, Lisa, Dr. Corbin, and Catie discuss:Mentorship as a driver of growth and opportunityThe mutual responsibilities within mentor–mentee relationshipsEarly guidance shaping confidence and career directionPaying forward lessons learned through mentoring othersKey Takeaways: Mentorship offers students personalized support, creating opportunities that money alone cannot provide.Advocating for oneself and asking for help early—whether in high school classrooms or college —can build the confidence needed to persist in challenging subjects.Successful mentorship is not about rigid schedules but about mentees taking initiative, showing preparedness, and seeking guidance when it's most needed.Recognition can follow when students demonstrate leadership by mentoring younger peers, developing rigorous learning systems, and fostering strong academic communities.“If you're a scientist in the STEM field, and you've never mentored anybody… I promise that any effort and time you spend mentoring will be rewarding, both for your mentee and for you.” – Dr. Karen Corbin“Mentorship has always been a really important aspect of my life, and I do think something I'm very good at is advocating for myself and asking for help.” – Catie KeanAbout Dr. Karen Corbin and Catie Kean: Dr. Karen Corbin is an Associate Investigator at the AdventHealth Translational Research Institute. Since August 2024, she has mentored Catie Kean through the Astronaut Scholarship Foundation, supporting her academic journey and professional development.Catie Kean is a 2024 Astronaut Scholar with the Astronaut Scholarship Foundation and a recent graduate with a Bachelor of Science in Biology and Biotechnology. She earned an Honorable Mention for the NSF Graduate Research Fellowship Program and will begin her PhD in Molecular, Cellular, and Developmental Biology at the University of Colorado Boulder in August 2025.Episode References:Explore more resources to support students' growth and clarity by visiting the free tools Join ASF's Mentorship Program to support the newly announced 2025 Astronaut Scholars and help shape the future of scienceGet Lisa's Free on-demand video: How-to guide for your teen to choose the right major, college, & career...(without painting themselves into a corner, missing crucial deadlines, or risking choices you both regret). Connect with the Astronaut Scholarship Foundation:Instagram: https://www.instagram.com/astroscholarfdn/?hl=en Facebook: https://www.facebook.com/AstroScholarFdn/LinkedIn: https://www.linkedin.com/company/astronaut-scholarship-foundation/Connect with Lisa:Website: https://www.flourishcoachingco.com/YouTube: https://www.youtube.com/@flourishcoachingcoFacebook: https://www.facebooke.com/flourishcoachingco/Instagram: https://www.instagram.com/flourishcoachingco/LinkedIn: https://www.linkedin.com/company/flourish-coaching-co

Savez-vous que les tanins, ces composés végétaux fascinants, sont bien plus qu'une simple curiosité de la nature ? Dans cet épisode d'ArtEcoVert, Pauline Leroux, ingénieure agronome passionnée de couleur végétale, reçoit Marc-André Sélosse, professeur au Muséum National d'Histoire Naturelle, pour un voyage captivant au cœur des tanins et de leur rôle essentiel dans la teinture végétale.Ensemble, ils plongent dans l'univers des plantes tinctoriales, explorant comment ces substances naturelles influencent non seulement la couleur des textiles mais aussi notre santé et notre environnement. Marc-André partage sa vision sur la vulgarisation scientifique, affirmant que la complexité des tanins peut être perçue comme une beauté. Il définit les tanins, explique leur rôle dans la teinture et souligne leur importance écologique, tout en évoquant des applications modernes dans des domaines variés tels que l'alimentation, la santé, et même la cosmétique.Découvrez comment les tanins interagissent avec les protéines, influençant des aspects comme l'astringence et la couleur, et comment ils peuvent être utilisés pour créer des colorants biosourcés d'une richesse inégalée. Les discussions techniques de cet épisode mettent en lumière l'importance de la biodiversité et de l'agriculture durable, tout en offrant un aperçu des perspectives d'avenir pour l'utilisation des tanins dans le bâtiment et d'autres secteurs innovants.Marc-André nous invite à réfléchir sur les nuances que peuvent offrir les pigments végétaux et les fibres naturelles, tout en soulignant l'importance de préserver notre patrimoine végétal. Que vous soyez un passionné de teinture végétale, un amateur de couleur végétale, ou simplement curieux d'en apprendre davantage sur les plantes et leur impact sur notre quotidien, cet épisode est fait pour vous.Ne manquez pas cette occasion d'enrichir vos connaissances et d'adopter une approche plus respectueuse de l'environnement grâce aux tanins et aux plantes tinctoriales. Écoutez dès maintenant cet épisode d'ArtEcoVert pour explorer un monde où la couleur et la nature se rencontrent de manière harmonieuse et durable. Belle écoute !ArtEcoVert informe et inspire celles et ceux qui veulent repenser la couleur autrement, et les accompagne dans leur transition vers une couleur plus durable — avec des témoignages concrets le jeudi

On the latest episode of the GZERO World podcast, Ian Bremmer talks with world-renowned cancer researcher and Pulitzer Prize-winning author Siddhartha Mukherjee about the future of medicine—and why artificial intelligence might finally tip the scales in the decades-long war on cancer.Cancer remains the second leading cause of death in the US, killing nearly 1,700 people every day. But Mukherjee says AI is already reshaping the field, from radiology and diagnostics to identifying new carcinogens and designing entirely new cancer drugs. “Every time we do this in collaboration with a machine,” he explains, “the machine learns it, and it learns it forever.”In a wide-ranging conversation, Mukherjee breaks down three major areas where AI is advancing medicine: patient care, data mining, and generative drug development. He also weighs in on early cancer detection, how inflammation may hold the key to understanding new carcinogens, and why this moment may be the most hopeful in half a century of cancer research.Host: Ian BremmerGuest: Siddhartha Mukherjee Subscribe to the GZERO World with Ian Bremmer Podcast on Apple Podcasts, Spotify, or your preferred podcast platform, to receive new episodes as soon as they're published.

On the latest episode of the GZERO World podcast, Ian Bremmer talks with world-renowned cancer researcher and Pulitzer Prize-winning author Siddhartha Mukherjee about the future of medicine—and why artificial intelligence might finally tip the scales in the decades-long war on cancer.Cancer remains the second leading cause of death in the US, killing nearly 1,700 people every day. But Mukherjee says AI is already reshaping the field, from radiology and diagnostics to identifying new carcinogens and designing entirely new cancer drugs. “Every time we do this in collaboration with a machine,” he explains, “the machine learns it, and it learns it forever.”In a wide-ranging conversation, Mukherjee breaks down three major areas where AI is advancing medicine: patient care, data mining, and generative drug development. He also weighs in on early cancer detection, how inflammation may hold the key to understanding new carcinogens, and why this moment may be the most hopeful in half a century of cancer research.Host: Ian BremmerGuest: Siddhartha Mukherjee Subscribe to the GZERO World with Ian Bremmer Podcast on Apple Podcasts, Spotify, or your preferred podcast platform, to receive new episodes as soon as they're published.

Saviez-vous que nos ancêtres Homo sapiens utilisaient déjà des teintures végétales il y a 34 000 ans ? Dans cet épisode captivant du podcast ArtEcoVert, nous avons le plaisir d'accueillir Pauline Leroux, ingénieure agronome passionnée par la couleur végétale et les plantes tinctoriales. Ensemble, nous plongeons dans une découverte archéologique fascinante qui remet en question notre compréhension des capacités créatives de nos ancêtres. Pauline nous fait découvrir une étude récente publiée dans la revue PLOS ONE, qui met en lumière des résidus de guède retrouvés dans la grotte de Dzudzuana, en Géorgie. Ces résidus, contenant de l'indigotine, prouvent que ces hommes préhistoriques savaient transformer les feuilles en couleurs, un processus chimique complexe qui nécessite observation et expérimentation. Cette révélation nous pousse à réfléchir à la manière dont la teinture végétale, qu'elle soit à base d'indigo, de garance, ou d'autres colorants biosourcés, a façonné notre rapport à l'art et à la couleur. Pauline souligne que cette quête d'esthétisme et de sens ne se limitait pas à la survie, mais s'étendait à une véritable exploration des nuances et des pigments végétaux. Comment ces pratiques anciennes influencent-elles notre compréhension de la couleur et de l'art aujourd'hui ? En écoutant cet épisode, vous découvrirez l'importance des fibres naturelles et des tanins dans la création de colorants végétaux, ainsi que l'impact de l'agriculture tinctoriale sur notre environnement et nos jardins. Ne manquez pas cette occasion d'approfondir vos connaissances sur les plantes tinctoriales et leur rôle dans notre histoire culturelle. Que vous soyez un passionné de couleur, un amateur d'art ou simplement curieux d'en savoir plus sur les trésors que nous offre le monde végétal, cet épisode d'ArtEcoVert est fait pour vous. Pour en savoir plus sur les sujets abordés, consultez les liens utiles dans la description. Belle écoute et laissez-vous inspirer par la voix de la couleur végétale avec Pauline ! ArtEcoVert informe et inspire celles et ceux qui veulent repenser la couleur autrement, et les accompagne dans leur transition vers une couleur plus durable — avec des témoignages concrets le jeudi

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. CDC Director Monarez was fired after less than a month due to internal unrest over new COVID-19 vaccine policies. Novo Nordisk is investing over $500 million in RNA obesity treatments. The FDA has approved updated COVID-19 shots from Pfizer, Moderna, and Novavax with restrictions, causing concern among some groups. Prothena's Alzheimer's drug, PRX012, has shown high rates of brain swelling in Phase I testing. Novo Nordisk is collaborating with other companies on cardiometabolic treatments. The pharma industry is facing challenges and changes, with layoffs and restructurings occurring at various companies. Massachusetts has seen a decline in R&D and biomanufacturing jobs in 2024. Various webinars and events are being held to discuss topics such as pharma manufacturing and data accessibility. Job opportunities in the pharmaceutical industry include positions in business analysis, quality engineering, and project engineering.

Biotechnology startup OGI Biotec adopted manufacturing software early on to get its fledgling production off the ground, a move that quickly proved beneficial. You can learn more in this episode or read about it on our blog For more information about MRPeasy software, visit our website: mrpeasy.com

Savez-vous que les couleurs que nous utilisons au quotidien peuvent être issues de la nature elle-même ? Dans cet épisode d'ArtEcoVert La voix de la couleur végétale et des plantes tinctoriales, plongez dans le monde fascinant de la teinture végétale avec notre hôte, Pauline Leroux, ingénieure agronome passionnée par les plantes tinctoriales. Elle nous guide à travers un voyage coloré, où la couleur végétale s'invite dans des domaines variés tels que le textile, l'ameublement, l'artisanat et la décoration.Rejoignez-nous pour une discussion captivante avec notre invitée, Estelle Defrance, qui présente le projet Gréouet. Ce projet innovant explore le potentiel bioactif d'extraits de plantes pour des applications cosmétiques. Estelle dévoile les résultats de ses recherches sur les capacités antioxydantes de divers extraits végétaux, mettant en lumière leur utilisation potentielle dans les formulations cosmétiques. Imaginez utiliser des colorants biosourcés comme l'indigo ou la garance pour non seulement embellir votre peau, mais aussi pour contribuer à une agriculture durable !Dans cet épisode, nous soulignons l'importance de valoriser les plantes et leurs coproduits, en promouvant une approche zéro déchet. Les pigments végétaux, les tanins et les fibres naturelles jouent un rôle essentiel dans cette démarche. Grâce à des initiatives comme celles d'ArtEcoVert, nous pouvons transformer notre perception de la couleur et de la teinture en intégrant des pratiques durables dans notre quotidien.Nous vous invitons à écouter cette conversation enrichissante et à réfléchir à la manière dont nous pouvons tous contribuer à un avenir plus vert. Que vous soyez passionné par les nuances de la teinture ou simplement curieux d'en apprendre davantage sur les jardins de plantes tinctoriales, cet épisode est fait pour vous !Enfin, n'oubliez pas de soutenir notre podcast et de suivre nos prochaines initiatives autour de la couleur végétale. Ensemble, faisons briller la beauté des couleurs naturelles ! Belle écoute !ArtEcoVert informe et inspire celles et ceux qui veulent repenser la couleur autrement, et les accompagne dans leur transition vers une couleur plus durable — avec des témoignages concrets le jeudi

Biotechnology company Genentech broke ground on its first east coast facility on Monday. It plans to hire 420 people in Holly Springs as it works on developing obesity drugs. WRAL's Shaun Gallagher explains what the company's plans are over the next five years.

Dr. Frank Bedu-Addo, President and CEO of PDS Biotechnology, focuses on the challenge of cancer recurrence and the development of a targeted immunotherapy approach using nanoparticle technology. Their lead immunotherapy candidate is designed to train the immune system to detect and attack microscopic or undetectable cancer cells, prolonging survival by preventing recurrence. Early clinical results in cervical, head and neck, and other HPV 16-positive cancers have been promising, showing sustained immune response leading to long-lasting T cell memory.  Frank explains, "Recurrence of cancer after treatment is actually one of the bigger hurdles we face in successfully treating cancer. So, PDS Biotechnology, as you know, we have a sharp focus on advancing our targeted immunotherapy platforms to address significant unmet needs in treating cancer. And this is actually one of those key unmet needs in cancer today. The prevailing hypothesis on knowledge is that cancer treatment, whether it's done using radiation therapy or anti-cancer drugs such as chemotherapy, both methods actually work by destroying cancer cells or halting the growth."   "And so what may happen with time is that these remaining cancer cells may then grow until they can be detected or begin to cause symptoms. Now, even if the cancer has been removed by surgery, there is still a risk that some tiny microscopic cancer cells could still remain in the body. We would therefore expect the ideal immunotherapy to be able to detect these tiny microscopic cancer cells, even if they have spread to other parts of the body."  #PDSBiotech #Cancer #CancerVaccines #ImmunoOncology #CancerRecurrence PDSbiotech.com Download the transcript here  

Dr. Frank Bedu-Addo, President and CEO of PDS Biotechnology, focuses on the challenge of cancer recurrence and the development of a targeted immunotherapy approach using nanoparticle technology. Their lead immunotherapy candidate is designed to train the immune system to detect and attack microscopic or undetectable cancer cells, prolonging survival by preventing recurrence. Early clinical results in cervical, head and neck, and other HPV 16-positive cancers have been promising, showing sustained immune response leading to long-lasting T cell memory.  Frank explains, "Recurrence of cancer after treatment is actually one of the bigger hurdles we face in successfully treating cancer. So, PDS Biotechnology, as you know, we have a sharp focus on advancing our targeted immunotherapy platforms to address significant unmet needs in treating cancer. And this is actually one of those key unmet needs in cancer today. The prevailing hypothesis on knowledge is that cancer treatment, whether it's done using radiation therapy or anti-cancer drugs such as chemotherapy, both methods actually work by destroying cancer cells or halting the growth."   "And so what may happen with time is that these remaining cancer cells may then grow until they can be detected or begin to cause symptoms. Now, even if the cancer has been removed by surgery, there is still a risk that some tiny microscopic cancer cells could still remain in the body. We would therefore expect the ideal immunotherapy to be able to detect these tiny microscopic cancer cells, even if they have spread to other parts of the body."  #PDSBiotech #Cancer #CancerVaccines #ImmunoOncology #CancerRecurrence PDSbiotech.com Listen to the podcast here  

Savez-vous que la majorité de l'indigo utilisé aujourd'hui est d'origine synthétique, entraînant des conséquences environnementales alarmantes ? Dans cet épisode d'ArtEcoVert, nous avons le plaisir d'accueillir Romain Vauquelin, un jeune chercheur passionné par la teinture végétale et les plantes tinctoriales, qui nous éclaire sur ses travaux de thèse novateurs. Romain, ingénieur agronome, se consacre à l'optimisation d'un procédé d'extraction de pigment indigo à partir de la plante Isatis tinctoria, une approche qui pourrait révolutionner le monde des colorants végétaux.Au fil de notre conversation, Romain partage avec nous les enjeux liés à la production d'indigo synthétique, notamment la pollution des eaux et les émissions de gaz à effet de serre. Il nous explique comment son approche d'extraction aqueuse permet de réduire l'impact environnemental tout en maximisant le rendement et la pureté des pigments extraits. En explorant les propriétés chimiques de l'indigo et de l'indirubine, il nous offre un aperçu fascinant des nuances et des possibilités qu'offrent les colorants biosourcés.Romain nous dévoile également les tests rigoureux qu'il a réalisés pour optimiser chaque étape du processus d'extraction, prouvant ainsi qu'il est possible de concilier innovation, durabilité et respect de l'environnement dans le domaine de la teinture. Cet épisode est une véritable ode à la couleur végétale, aux pigments végétaux et aux fibres naturelles, et nous invite à repenser notre rapport à la teinture et à l'agriculture tinctoriale.Ne manquez pas de suivre notre actualité sur la page Instagram d'ArtEcoVert pour découvrir les prochains invités qui partageront leur expertise et leurs expériences dans le monde fascinant des plantes tinctoriales. Votre soutien est précieux, alors n'hésitez pas à laisser vos commentaires et notes pour nous aider à faire grandir cette belle aventure dédiée à la couleur et à la nature.Nous espérons que vous apprécierez cet épisode autant que nous avons aimé le réaliser. Belle écoute !ArtEcoVert informe et inspire celles et ceux qui veulent repenser la couleur autrement, et les accompagne dans leur transition vers une couleur plus durable — avec des témoignages concrets le jeudi

We've long marveled at how efficiently plants convert sunlight into energy—but no one guessed they were using quantum mechanics to do it.In this episode, we speak with Greg Engel, a pioneering University of Chicago biophysicist who helped launch the field of quantum biology. Engel explains how plants and bacteria evolved to exploit quantum effects for photosynthesis—and how understanding these systems could spark a revolution in quantum sensing, medicine, and neuroscience.Engel's team has already built quantum sensors inspired by nature's designs, with the potential to transform how we detect disease, develop drugs, and even read neural signals. The ultimate goal? A new era of quantum medicine, powered by the weird and wonderful physics found in leaves.

The Katrina 20 Local Planning Committee is commemorating Hurricane Katrina with performances, art and more, throughout the city, stretching to Mississippi and Alabama.The Coastal Desk's Eva Tesfaye spoke with Asali deVan Ecclesiastes, executive director of the Ashé Cultural Arts Center, to learn more about the events and how you can get involved. For months, the Trump administration has been cutting funding for university-based scientific research across the nation. But the Louisiana Biomedical Research Network recently logged a ‘win'with the renewal of one of its grants from the National Institute of Health–$20 million spread out over five years.Dr. Konstantin "Gus" Kousoulas, a professor and department head in the LSU School Veterinary Medicine's Department of Pathobiological Sciences and director of their Division of Biotechnology and Molecular Medicine, joined us to discuss the grant and how it will be used.—Today's episode of Louisiana Considered was hosted by Adam Vos. Our managing producer is Alana Schreiber. We get production support from Garrett Pittman and our assistant producer Aubry Procell.You can listen to Louisiana Considered Monday through Friday at noon and 7 p.m. It's available on Spotify, the NPR App and wherever you get your podcasts. Louisiana Considered wants to hear from you!Please fill out our pitch line to let us know what kinds of story ideas you have for our show. And while you're at it, fill out our listener survey! We want to keep bringing you the kinds of conversations you'd like to listen to.Louisiana Considered is made possible with support from our listeners. Thank you!

Welcome to the Securing Our Future podcast, where we explore the synergy between commercial innovation and national security. In this episode, we sit down with Dawn Meyerriecks, an expert with over 40 years of experience in government and industry, to discuss the profound technological advancements from Desert Storm to AI and quantum computing. Dawn shares insights into the adoption of new technologies, the role of government and private sectors, and the importance of finding the right champions for innovation. We also delve into the emerging field of biotechnology and its transformative implications for national security. Join us for an engaging conversation that bridges the gap between innovation and security.00:00 Introduction to Securing Our Future Podcast00:41 Guest Introduction: Dawn's Storied Career01:05 Technological Evolution and National Security02:49 Challenges of Rapid Technological Change04:27 Leadership and Innovation in Government06:37 Startups and Government Collaboration12:34 Biotechnology and National Security19:00 Future Directions and Personal Reflections25:20 Closing Remarks and Acknowledgements

Saviez-vous que près de 30% des sols européens sont contaminés, mettant en péril notre écosystème et notre santé ? Dans cet épisode d'ArtEcoVert, nous avons le plaisir d'accueillir Pauline Leroux, ingénieure agronome et passionnée de couleur végétale, qui nous plonge au cœur de l'univers fascinant des plantes tinctoriales. Avec une expertise indéniable, elle nous éclaire sur les enjeux cruciaux liés à la pollution des sols et nous présente des statistiques alarmantes sur les sites pollués en Europe et en France.Pour enrichir notre discussion, Anissa Lounes, experte invitée, partage son savoir sur le phytomanagement, une approche innovante qui transforme les sols pollués en véritables opportunités. Grâce à l'utilisation de plantes, non seulement nous pouvons dépolluer les sols, mais également créer de nouvelles filières alimentaires durables. Ensemble, nous explorons des projets concrets, comme le projet DéfiWaide, qui met en avant le potentiel des plantes non alimentaires pour réhabiliter les sols, tout en intégrant des techniques de teinture végétale.Au cours de cet épisode, nous mettons en lumière la plante Isatis tinctoria, connue pour sa capacité à produire de l'indigo. Cette plante pourrait jouer un rôle essentiel dans la phytorémédiation, offrant non seulement une solution à la pollution, mais également des colorants biosourcés pour la teinture. Les résultats préliminaires de nos recherches montrent que l'Isatis tinctoria peut non seulement survivre dans des sols contaminés, mais aussi contribuer à leur réhabilitation écologique et microbiologique.Cet épisode est bien plus qu'une simple discussion sur les plantes tinctoriales ; c'est une invitation à repenser notre rapport à la nature et à la couleur végétale. Nous vous encourageons à découvrir comment des solutions durables et innovantes peuvent répondre aux problèmes environnementaux actuels, tout en célébrant la beauté des nuances offertes par les colorants végétaux. Que vous soyez passionné de jardinage, d'agriculture tinctoriale ou simplement curieux des possibilités offertes par les pigments végétaux, cet épisode est fait pour vous.Rejoignez-nous pour cette conversation enrichissante et engageante, où nous partageons des expériences, des techniques et des visions pour un avenir plus vert et coloré. N'oubliez pas d'écouter jusqu'à la fin pour découvrir des ressources utiles et des liens vers des projets inspirants. Belle écoute !ArtEcoVert informe et inspire celles et ceux qui veulent repenser la couleur autrement, et les accompagne dans leur transition vers une couleur plus durable — avec des témoignages concrets le jeudi

Biotechnology is strategically important because of its potential to transform humanity's control over nature. Governments worldwide are racing to secure their positions in the field – and China is no exception. MERICS experts Alexander Brown and Jeroen Groenewegen-Lau join Johannes Heller-John to discuss the rise of China in biotechnology. They are the authors of the report “Lab leader, market ascender: China's rise in biotechnology”, published earlier this year. Research for the report is part of the MERICS China Tech Observatory (CTO), a project funded by the Ministry of Research, Technology and Space (BMFTR) under funding reference number 01DO24001.

Savez-vous que la teinture végétale, avec ses nuances éclatantes et ses propriétés écologiques, pourrait transformer notre approche du textile ? Dans cet épisode captivant du podcast ArtEcoVert, Pauline Leroux, ingénieure agronome passionnée par la couleur végétale, nous entraîne dans un voyage fascinant à travers l'univers des plantes tinctoriales. Elle est accompagnée d'Usha Massika Behary, experte en colorants naturels, qui nous dévoile les secrets de l'indigo et d'autres pigments végétaux utilisés dans le textile.Usha partage avec nous des informations précieuses sur l'utilisation durable de ces colorants biosourcés, en mettant en lumière leurs propriétés multifonctionnelles, telles que l'antibactérien et la protection UV. Elle aborde également les défis liés à la teinture avec l'indigo, notamment les méthodes de fixation et les tests de stabilité des colorants. Ces discussions techniques nous permettent de mieux comprendre l'importance de l'agriculture tinctoriale et son impact sur l'environnement.En parallèle, Pauline souligne l'urgence de démocratiser l'usage des couleurs végétales dans divers domaines, du textile à l'artisanat, en passant par les jardins. Elle évoque les innovations récentes dans le domaine des colorants végétaux et les avantages indéniables qu'ils apportent, tant esthétiques qu'écologiques. Ensemble, elles explorent les multiples facettes de la teinture végétale et son potentiel pour créer un avenir plus durable.« La couleur végétale est une invitation à redécouvrir notre lien avec la nature », déclare Pauline. À travers cet épisode, découvrez comment les fibres naturelles et les tanins des plantes peuvent offrir des alternatives viables aux colorants synthétiques, tout en préservant notre environnement. Les nuances et la richesse des pigments végétaux nous rappellent que la beauté peut rimer avec durabilité.Ne manquez pas cette occasion d'en apprendre davantage sur les trésors que nous offre la nature et comment ils peuvent transformer notre quotidien. Que vous soyez un passionné de mode, un artisan ou simplement curieux d'en savoir plus sur la teinture végétale, cet épisode est fait pour vous ! Pour aller plus loin, n'hésitez pas à consulter notre site pour des ressources supplémentaires sur les plantes tinctoriales et les innovations dans le domaine des colorants biosourcés.Nous vous souhaitons une belle écoute et espérons que cet épisode vous inspirera à explorer le monde vibrant de la teinture végétale et des plantes qui la rendent possible. Rejoignez-nous dans cette aventure colorée et engagée avec ArtEcoVert !ArtEcoVert informe et inspire celles et ceux qui veulent repenser la couleur autrement, et les accompagne dans leur transition vers une couleur plus durable — avec des témoignages concrets le jeudi

ORIGINAL AIR DATE: AUG 2, 2015An amazing conversation from a decade ago with the amazing Dr. Thomas Horn, on the subject of Transhumanism.Here is the documentary Tom refers to: https://www.youtube.com/watch?v=8QG1EgkpJX4Sheila's content is viewer supported.SHEILA WEBSITE: https://sheilazilinsky.comHOW TO GIVE: https://sheilazilinsky.com/givingVenmo https://venmo.com/u/SheilaZilinskyCash app https://cash.app/$SheilaZilinskyZelle sheila@sheilazilinsky.comPayPal https://www.paypal.com/paypalme/sheilazilinskyPatreon https://www.patreon.com/sheilazilinskyHOW TO LISTEN:BRAND NEW YOUTUBE CHANNEL https://www.youtube.com/@realsheilazRumble: https://rumble.com/user/RealSheilaZPodcast: https://www.podomatic.com/podcasts/sheilazilinskyApple Podcast: https://podcasts.apple.com/ca/podcast/the-sheila-zilinsky-show/id960689559FOLLOW SHEILA:Telegram: https://t.me/realsheilazTwitter: https://twitter.com/RealSheilaZFacebook: https://www.facebook.com/realSheilaZInstagram: https://www.instagram.com/sheilazilinskySubstack: https://sheilazilinsky.substack.com

Send me a DM here (it doesn't let me respond), OR email me: imagineabetterworld2020@gmail.comToday I'm honored to introduce you all to: Ritual Abuse, MK ULTRA, and organized abuse survivor, overcomer and thriver, content creator and podcast host of her own YouTube channel called “From PTSD to a Graduate Degree', artist and creative, scientific innovator and revolutionary, my new friend, and a woman pushing the boundaries on overcoming fear and trauma: Amy BergerBorn on January 3, 1977, in Whitestone, NY, Amy emerged from a childhood shadowed by profound adversity. Raised in a severely dysfunctional home, Amy endured a mother's untreated PTSD and level 5 hoarding, alongside a father's emotional abuse and crack addiction. From ages 9 to 18, she suffered molestation by her half-brother, leaving deep emotional wounds that fueled fear, self-harm, obsessive-compulsive behaviors, and teenage prostitution as a desperate survival mechanism. “I was not okay,” Amy reflects, her early years saturated with terror and devoid of tools to navigate it.1999, a seismic shift occurred. Amy began recovering suppressed memories of additional sexual abuse by family members and babysitters, followed by revelations of ritual abuse and MK ULTRA This turning point split her life into two: before memories and after. Through years of trauma therapy, she pieced together her psychological architecture, confronting paralyzing terror and periods of disability that left her reliant on social security.Yet Amy's story is one of relentless resilience. A few years ago, seeking distraction from fear, she returned to school - a decision that transformed her life. Now a senior Biology major at Worcester State University, Amy is poised to pursue a double master's in Biotechnology and Artificial Intelligence at WPI. Her ambition is laser-focused: to revolutionize synthetic biology by targeting the FAAH gene to eliminate the fear response at its genetic root. Inspired by the rare genetic mutation of Jo Cameron, who feels no pain or anxiety, Amy aims to rewrite the biochemical terms of terror, stripping away the leverage trauma and cult programming hold over survivors like herself.In her inspiring YouTube video series, From PTSD to a Graduate Degree, Amy shares her journey with raw honesty. “How do I do it?” she asks, detailing the scaffolding that supports her success: two trauma-specialized therapists, open communication with professors, healthy social connections, and a disciplined yet gentle study routine. Even on days when anxiety surges, Amy stays ahead, having only missed three classes in two years. Her scientific passion drives her to explore groundbreaking research, collaborating with AI to design a study on FAAH gene modulation to enhance fear extinction - a project she hopes to develop as a graduate thesis.Amy's vision is bold and personal: to create a world where no one feels the crippling fear she once did. Her journey from a shattered childhood to a pioneering scientist is a testament to the power of resilience, education, and an unwavering commitment to rewriting her story - and the future of human emotional experience. “I've come a tremendously long way,” she says on one of her YouTube videos, her voice a beacon of hope for others. With a groundbreaking study on FAAH gene modulation already taking shape, Amy isn't just healing herself - she's igniting a revolution, paving the way for a fearless future where every soul can find safety, stability, and boundless possibility - proving that even the deepest wounds can fuel extraordinary change.CONNECT WITH AMY: YouTube: @FromPTSDtoaGraduateDegree - Support the show

Savez-vous que la nature regorge de trésors colorés qui peuvent transformer nos textiles et notre décoration ? Dans cet épisode captivant du podcast ArtEcoVert, nous plongeons dans l'univers fascinant des plantes tinctoriales et de la teinture végétale avec notre invitée, Pauline Leroux, ingénieure agronome passionnée par la couleur végétale. Ensemble, nous explorerons les multiples applications de ces pigments végétaux dans le monde du textile, de l'artisanat et de la décoration.Accompagnée de David Brunel, expert en indigo et fervent défenseur de la réintroduction de la plante tinctoriale Oued en Picardie, Pauline nous raconte comment ils ont su raviver une tradition perdue. David partage avec nous l'histoire émouvante de la relance de cette culture après la perte tragique de l'un des fondateurs, ainsi que le processus minutieux de culture et d'extraction de l'indigo. Grâce à leur collaboration avec l'université de Béthune, ils innovent sans cesse dans l'extraction des colorants biosourcés, tout en intégrant des pratiques durables et respectueuses de l'environnement.Au fil de la discussion, vous découvrirez l'importance des fibres naturelles et des tanins dans la création de nuances uniques et durables. Les deux experts abordent également les défis et les succès rencontrés dans leur démarche d'agriculture tinctoriale et soulignent l'impact positif de ces initiatives sur notre écosystème. En fin d'épisode, un appel à l'action vous sera lancé : soutenez le podcast et suivez leurs projets inspirants sur Instagram.Ne manquez pas cet épisode riche en enseignements, qui vous donnera un nouvel aperçu des merveilles de la teinture végétale et des plantes tinctoriales. Que vous soyez un passionné de couleurs ou simplement curieux d'en savoir plus sur les pigments végétaux, cet échange vous ouvrira les portes d'un monde où la nature et la créativité se rencontrent. Belle écoute !ArtEcoVert informe et inspire celles et ceux qui veulent repenser la couleur autrement, et les accompagne dans leur transition vers une couleur plus durable — avec des témoignages concrets le jeudi

On the eve of another school year, we speak with Dr. John Swallow, the president of Carthage College. He tells us about the record-breaking freshman class that is about to begin studies at Carthage - the creation of a School of Health - and the offering of a new Biotechnology major/minor.

The biotech at the fingertips of farmers is super exciting. But is regulation keeping pace with scientific leaps?Biotech like gene editing has the potential to revolutionise the industry - by not only enhancing crop yields, but supporting sustainable farming practices, and helping address global climate change and food security. Michael Leader's job with Bayer is an interesting one - he's the bridge connecting the science labs and the regulators; translating complex new biotech innovation to policy makers.  In this chat Michael discusses the legislative hurdles for biotech, use of AI in new crop protection technologies, the new biotech in the pipeline for farmers, and the careers in agriculture that go beyond the paddock.  Michael Leader is the Regulatory Policy & Stakeholder Engagement Manager for the Asia region, for Bayer Crop Science Australia. TakeawaysMichael's background in law and molecular biology, and now working in regulatory policy in agricultureThe opportunities in the Asian region for applying biotech, with policy stagnating ag innovation tools to dateBiotechnology has evolved significantly over the past 30 years but GM breeding typically takes 16 years to get to market and $100m in research and regulatory costsActivism continues to challenge the acceptance of biotechnologyThere is a need for regulatory reform to accommodate new technologiesThe lack of distinction between the definitions of 'genome editing' and 'genetically modified' is inhibiting workable regulatory frameworkFuture agricultural innovations could address climate change and food securityBayer is proactive with transparency, showing their biotech studies online and using Open Labs 360, a self-guided virtual reality tour of labs and fields to understand regulatory and safety dataChapters03:06 The Intersection of Law and Molecular Biology05:58 Career Journey in Regulatory Policy09:03 Current Work and Responsibilities at Bayer12:08 Opportunities in Asian Agriculture17:57 Challenges and Misconceptions in Biotechnology23:55 Regulatory Hurdles in Biotechnology26:58 Future of Agricultural InnovationLinks:Learn more about Bayer Australia and New Zealand, follow them on Facebook, Instagram and LinkedInMore episodes at Humans of AgricultureThis is a sponsored series in partnership with Bayer Crop Science Australia, showcasing Bayer's commitment to innovation; supporting Aussie agriculture and backing rural communities. 

Êtes-vous prêt à plonger dans le monde fascinant des teintures végétales et des plantes tinctoriales? Dans cet épisode captivant d'ArtEcoVert, nous avons le plaisir d'accueillir Pauline Leroux, ingénieure agronome passionnée, qui nous dévoile les secrets des colorants naturels, notamment ceux dérivés de l'Isatis tinctoria, communément appelée Waid. Ensemble, nous explorerons non seulement les nuances incroyables que cette plante peut offrir, mais aussi son rôle crucial dans la valorisation des ressources agricoles.Rejoint par Patrick Martin de l'UTA, cet épisode met en lumière les résultats d'un projet de recherche cofinancé par la région Hauts-de-France, axé sur l'importance des chaînes de valeur durables. En effet, comment peut-on tirer profit des coproduits agricoles pour créer des pigments végétaux sans laisser de déchets? Nos experts discutent des méthodes innovantes d'extraction des colorants, y compris ceux issus de pelures d'oignons, et des applications variées dans les domaines du textile et de la cosmétique.« La nature nous offre des trésors insoupçonnés », souligne Pauline, alors qu'elle nous guide à travers les techniques d'extraction des colorants biosourcés. Cet épisode est une véritable ode à l'innovation et à la recherche dans le domaine de la couleur végétale, tout en appelant à une prise de conscience écologique essentielle. Comment les tanins et autres éléments des fibres naturelles peuvent-ils transformer notre approche de la teinture? C'est une question à laquelle nous tenterons de répondre ensemble.Nous vous invitons à découvrir comment l'agriculture tinctoriale peut non seulement enrichir notre palette de couleurs, mais aussi contribuer à un avenir plus durable. Avec une approche engagée et pédagogique, cet épisode d'ArtEcoVert vous offre une perspective unique sur le monde des colorants végétaux et des plantes qui les produisent. Que vous soyez amateur de jardins ou simplement curieux des nuances que la nature peut nous offrir, vous trouverez ici des informations précieuses et inspirantes.Ne manquez pas cette occasion d'en apprendre davantage sur les enjeux écologiques et les possibilités infinies qu'offre le monde des teintures végétales. Pour plus de ressources et d'informations, n'hésitez pas à consulter notre site. Belle écoute!ArtEcoVert informe et inspire celles et ceux qui veulent repenser la couleur autrement, et les accompagne dans leur transition vers une couleur plus durable — avec des témoignages concrets le jeudi

In this episode, National Defense discusses the U.S.-China biotechnology race, the status of hypersonic weapons programs in the United States and a recent NATO amphibious exercise. 

Saviez-vous que certaines plantes tinctoriales peuvent non seulement colorer nos textiles, mais aussi influencer notre santé de manière significative ? Dans cet épisode d'ArtEcoVert, Pauline Leroux, ingénieure agronome passionnée par la couleur végétale, reçoit Catherine Daquet, experte en pharmacologie, pour une discussion fascinante sur les propriétés des plantes tinctoriales et leur impact sur notre bien-être. Ensemble, elles explorent comment des éléments tels que les anthocyanes et les flavonoïdes, présents dans des plantes comme l'indigo et la garance, peuvent jouer un rôle crucial dans la régulation de la pression artérielle, la glycémie et l'inflammation.Catherine partage également ses recherches approfondies sur les effets pharmacologiques des colorants végétaux, mettant en lumière des applications thérapeutiques concrètes qui pourraient transformer notre approche de la santé. Les défis liés à la pharmacocinétique et à la toxicité des extraits végétaux sont abordés avec rigueur, soulignant la nécessité de poursuivre les études sur ces pigments végétaux pour mieux comprendre leurs implications. Comment ces colorants biosourcés peuvent-ils moduler notre réponse immunitaire et réduire le stress oxydatif ? Les réponses vous surprendront !Dans cet épisode, vous découvrirez également l'importance des fibres naturelles et des tanins dans le cadre de l'agriculture tinctoriale, et comment ces éléments contribuent à créer des nuances uniques dans la teinture végétale. Les jardins de plantes tinctoriales, véritables laboratoires de couleurs, sont mis en avant comme des espaces d'expérimentation et de découverte. Les discussions techniques entre Pauline et Catherine sont enrichissantes et accessibles, offrant une perspective nouvelle sur la relation entre couleur, santé et nature.Ne manquez pas cette occasion d'approfondir vos connaissances sur les plantes, la couleur et les bienfaits qu'elles peuvent apporter à notre quotidien. L'épisode d'ArtEcoVert est une véritable invitation à explorer le monde fascinant des colorants végétaux et leur impact sur notre santé. Pour en savoir plus, restez à l'écoute et plongez dans cet univers où la couleur végétale rencontre la science.Pour écouter cet épisode et découvrir d'autres contenus passionnants sur les plantes tinctoriales et la teinture, rendez-vous sur notre site. Belle écoute !ArtEcoVert informe et inspire celles et ceux qui veulent repenser la couleur autrement, et les accompagne dans leur transition vers une couleur plus durable — avec des témoignages concrets le jeudi

In this episode of the Fitness + Technology Podcast, host Bryan O'Rourke sits down with Jeff Zwiefel, Executive Director of Longevity & Performance at Life Time. With over three decades of leadership in the health, fitness, and wellness industry, Jeff brings a wealth of experience in strategic planning, brand evolution, and operational excellence. As a key architect behind Life Time's transformation into a comprehensive healthy lifestyle company, Jeff shares his perspective on the future of wellness, the role of leadership in culture and innovation, and strategies for advancing health span and performance.  Tune in for a powerful conversation filled with insights from one of the industry's most influential leaders. One Powerful Quote: 25:57: “We have two lives, and the second one begins when we realize we only have one.” 4-10 Bullet Points (w/ timestamps) - Highlighting key topics discussed: 2:04: Bryan opens the conversation with an overview of Jeff's extensive background and career journey. 4:33: The discussion turns to market bifurcation, as Bryan asks Jeff about evolving consumer demands and value delivery. Jeff explains how Life Time has strategically scaled to meet these shifting dynamics. 8:46: Bryan and Jeff explore the role of customer personas and how these insights influence alignment across the entire organization. 11:54: Jeff highlights emerging trends in health and wellness and shares how Life Time is innovating to meet these demands through enhanced service offerings. 17:00: The conversation delves into biotechnology and its growing influence on extending health span and optimizing performance. 20:16: Jeff discusses how Life Time maintains a strong cultural foundation while operating at scale, emphasizing the importance of human connection in large organizations. 24:37: Jeff concludes with key takeaways and lasting insights for listeners, offering wisdom from his decades of leadership in the industry. Bullet List of Resources: https://jeffzwiefel.com/ https://www.lifetime.life/ https://hbr.org/2008/07/putting-the-service-profit-chain-to-work Guest Contact Information: https://www.linkedin.com/in/jeffzwiefel/ https://x.com/JeffZwiefel https://www.bryankorourke.com/ https://www.linkedin.com/in/bryankorourke/ http://www.fittechcouncil.org/ https://www.youtube.com/user/bko61163

For episode 565 of the BlockHash Podcast, host Brandon Zemp is joined by Shahaf Bar-Geffen, CEO of COTI.Shahaf has been the CEO of COTI for more than four years now. He has also been part of the COTI founding team. He is known as the founder of WEB3, an online marketing group, as well as Positive Mobile, both of which were acquired. Shahaf studied Computer Science, Biotechnology and Economics in Tel-Aviv University. On top of that, he has had a long and impressive career in the Air Force. Learn more at https://www.coti.io ⏳ Timestamps: (0:00) Introduction(1:12) Who is Shahaf?(3:55) What is COTI?(8:34) What holds back adoption of blockchain?(10:23) How does COTI work?(12:54) Use-cases(16:32) Balancing Privacy with Compliance (20:33) COTI performance benchmarks(24:02) COTI roadmap in 2025(28:28) COTI website, socials & community 

Êtes-vous prêt à plonger dans l'univers vibrant des plantes tinctoriales et à découvrir comment la couleur végétale peut transformer notre monde ? Dans cet épisode captivant d'ArtEcoVert, nous avons le plaisir d'accueillir Pauline Leroux, ingénieure agronome passionnée par la teinture végétale, qui nous guide à travers les nuances fascinantes que les plantes peuvent offrir. Accompagnée de Laurent Lenglet, expert du Centre Technique du Papier, cette discussion promet d'être enrichissante et éclairante sur l'utilisation des colorants végétaux dans les encres et pigments.Laurent partage avec nous les défis et les opportunités liés à l'éco-conception des encres, en mettant en lumière la transition nécessaire des pigments synthétiques vers des alternatives biosourcées. Ensemble, ils explorent l'importance de la couleur végétale dans divers domaines, tels que le textile, l'artisanat, et l'emballage. Comment ces innovations peuvent-elles contribuer à un avenir plus durable ? Quelle place pour l'indigo, la garance, et les tanins dans cette évolution ?Ce dialogue technique et engagé aborde également les enjeux environnementaux liés aux encres d'imprimerie, soulignant l'impact des choix que nous faisons sur notre planète. La recherche et l'innovation sont essentielles pour intégrer les pigments végétaux dans l'industrie moderne, et cet épisode vise à sensibiliser le public à cette transition indispensable. En découvrant les fibres naturelles et les colorants biosourcés, vous serez inspiré à repenser vos pratiques et à envisager comment vous pouvez participer au mouvement vers une agriculture tinctoriale plus respectueuse de l'environnement.Ne manquez pas cette opportunité d'en apprendre davantage sur le pouvoir des plantes et de la couleur dans notre quotidien. Écoutez dès maintenant cet épisode d'ArtEcoVert et laissez-vous inspirer par les possibilités infinies que la teinture végétale a à offrir. Belle écoute !ArtEcoVert informe et inspire celles et ceux qui veulent repenser la couleur autrement, et les accompagne dans leur transition vers une couleur plus durable — avec des témoignages concrets le jeudi

Chemical engineer Beth Sattely studies the intricate chemistry of plant life. Plants are more than food, she says: They are living chemical factories churning out molecules that help plants do everything from adapting to climate change to fighting infections – or even producing valuable new cancer drugs. Lately, Sattely's lab is working on ways to make crops more resilient to engineer more sustainable foods and environments. Some of our most exciting technologies already exist in nature, we just have to find them, Sattely tells host Russ Altman on this episode of Stanford Engineering's The Future of Everything podcast.Have a question for Russ? Send it our way in writing or via voice memo, and it might be featured on an upcoming episode. Please introduce yourself, let us know where you're listening from, and share your question. You can send questions to thefutureofeverything@stanford.edu.Episode Reference Links:Stanford Profile: Elizabeth SattelyConnect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>> Twitter/X / Instagram / LinkedIn / FacebookChapters:(00:00:00) IntroductionRuss Altman introduces guest Beth Sattely, a professor of chemical engineering at Stanford University.(00:03:10) Path to Plant MetabolismHow chemistry and gardening led to a career in plant science.(00:03:54) Environmental and Human HealthUsing plants to improve both the planet and people's well-being.(00:04:53) Engineering Climate-Resilient CropsMaking crops more sustainable and nutritious amid global change.(00:05:58) Old vs. New Crop EngineeringComparing traditional breeding with modern molecular tools.(00:08:04) Industry and Long-Term Food SecurityThe gap between short-term market goals and long-term environmental needs.(00:09:13) Tomato ChemistryTomatoes reveal how plants produce protective molecules under stress.(00:12:26) Plant “Vaccines” and Immune SignalingHow plants communicate threats internally and mount chemical defenses.(00:14:14) Citrus Greening and LimonoidsThe potential role of limonoid research on citrus greening.(00:16:59) Plants Making MedicineHow plants like Yew trees naturally produce cancer drugs like Taxol.(00:21:19) Diet as Preventative MedicineIdentifying plant molecules to understand their preventative health effects. (00:24:36) Food Allergies and Plant ChemistryWhy the immune system tolerates some foods and rejects others.(00:26:42) Understanding Tolerance in ImmunityPossibility of reintroducing tolerance through partial molecular exposure.(00:28:02) Engineering Healthier PlantsPotential for designing plants to enhance micronutrient content.(00:29:04) Training the Next GenerationBeth celebrates her students' role in shaping a sustainable future.(00:30:39) Conclusion Connect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>>Twitter/X / Instagram / LinkedIn / Facebook

July 15, 2025 | Are licensing fees required or gatekeeping? In this episode of The Chain, host Nimish Gera, vice president of Biologics at Mythic Therapeutics, and Ian Wilkinson, CEO of Gamma Proteins, discuss accessing antibody discovery technology through licensing fees and royalties—and whether these fees are justified or not. Wilkinson delves into the current landscape of antibody discovery technologies, including if AI-based technology warrants fees, how royalties affect both small companies and big pharma, and his background as one of the first experts in the field who offered purely free-for-service options. He also shares what excites him about antibody engineering and beyond. Links from this episode:  Mythic Therapeutics Gamma Proteins 

The line between groundbreaking innovation and controversial ownership blurs when scientists begin creating life in laboratories. What happens when your invention isn't just a device or chemical formula, but a living, breathing, self-replicating organism that refuses to stay contained within traditional legal boundaries?Synthetic biology—the field where engineering meets genetics—has created a perfect storm for intellectual property law. Scientists can now design cells like software, program bacteria to clean oil spills, and edit genes with CRISPR technology. But who owns these inventions when they start reproducing themselves?From the landmark 1980 Chakrabarty decision that first allowed patents on genetically modified bacteria to the controversial Myriad Genetics case that determined human genes cannot be patented, we explore the fascinating legal battles that shaped biotech innovation. We journey through courtrooms worldwide where judges grappled with unprecedented questions: Can you patent a cloned sheep? Should farmers be allowed to replant patented seeds? Does traditional knowledge about medicinal plants deserve protection from corporate "biopiracy"?The legal landscape continues evolving, with a brand new WIPO treaty requiring disclosure of genetic resources' origins in patent applications. This represents a major shift toward transparency and fairness, especially for communities whose biodiversity and traditional knowledge have contributed to modern innovations.Whether you're a scientist, lawyer, entrepreneur, or simply curious about the legal frameworks governing emerging technologies, this episode offers crucial insights into how intellectual property systems are adapting to the brave new world where the line between invention and life itself becomes increasingly blurred. Subscribe to Intangiblia for more explorations of the fascinating intersection of law, technology, and innovation.Send us a text

Dr. Paul Nelson is our guest. He's the associate pastor of Sovereign Grace Baptist Church of Silicon Valley in Morgan Hill, CA; and also serves as the president of Grace Bible University; and a board member, and involved in numerous missionary efforts, with FirstLove Ministries. He shares about his fascinating journey through life as he switched his emphasis from the field of Biotechnology with a doctorate in chemistry, to what he felt was an undeniable call to the ministry!

I sat down with Brian H. Davison, PhD, Chief Scientist of Systems Biology & Biotechnology in the Biosciences Division of Oak Ridge National Laboratory and the Center for Bioenergy Innovation. Brian is a graduate of the University of Rochester and Caltech and candidate for President of the American Institute for Chemical Engineering (AIChE). Brian discusses his career trajectory from bench scientist to Chief Scientist, science communication, skills needed for effective leadership, discovery and commercialization, and his long history of leadership in AIChE and what he would aim to accomplish as President.

On this week's Inside Startup Investing, Dr. Nicole Paulk—founder & CEO of Siren Biotechnology—details her AAV gene-therapy “FedEx truck” that can deliver anti-tumor cytokines directly to brain cancers. Early animal data show 86 % complete responses; the FDA has signaled a fast-track path for Siren's first-in-human trial set for 2026. With analog comps like Keytruda earning $30 B a year, Siren's upside—and impact—could be enormous.Highlights include...Why viruses? AAV viruses don't cause disease in humans yet efficiently deliver genetic payloads; Siren re-engineers them to express anti-tumor cytokines.Twin “firsts.” Siren pursues the first AAV-based cancer therapy and the first single virus platform scalable to hundreds of indications.Animal data. >500 mouse models show 86 % complete responses; large-animal pig study indicates strong safety with real-world neurosurgical delivery.Clinical plan. Combined Phase 1/2 trial in adults with recurrent high-grade gliomas targeted for 2026 with potential for rare-disease (orphan) fast-track.Market context. Current SOC for brain tumors is largely ineffective; analogous immunotherapies like Keytruda generate ~$30 B annually.

Marianne De Backer is the CEO of Vir Biotechnology, a company developing treatments that harness the power of the immune system to fight serious infectious diseases and cancer. Vir Biotechnology's current clinical trials include a registrational program in chronic hepatitis delta, a rare, often fatal liver disease, as well as two Phase 1 trials of PRO-XTEN™ dual-masked T-cell engagers (TCEs), one targeting HER-2 and the other targeting PSMA, each in heavily pre-treated cancer patients. TCEs have shown tremendous potential but have been limited due to toxicity challenges. The PRO-XTEN™ technology keeps the TCEs masked until they reach the tumor microenvironment, potentially mitigating the toxicity of TCEs and allowing them to unleash their tremendous potential to destroy cancer cells.  Marianne explains, “Vir Biotechnology is an immunology company, and that means that we are really developing treatments that take advantage of the power of basically the patient's own immune system to fight a variety of diseases. We have actually four clinical-stage programs in infectious disease and oncology, and a number of preclinical programs as well. And our most advanced program is to treat chronic hepatitis delta. That is actually a disease caused by a tiny virus, but it's causing liver cancer and is often fatal.” “We have recently initiated our registrational phase 3 program. It's called ECLIPSE. We had previously shown some very compelling data with one of our regimens for treating this disease. We're really excited about progressing that program. And the rest of our clinical pipeline includes a series of so-called PRO-XTEN™ masked T-cell engagers, or in short, TCEs, for the treatment of metastatic solid tumors.”   Vir Biotechnology has exclusive rights to the PRO-XTEN™ masking platform for oncology and infectious disease. PRO-XTEN™ is a trademark of Amunix Pharmaceuticals, Inc. a Sanofi company. #VirBiotechnology #MaskedTCellEngagers #TCellEngagers #SolidTumors #MetastaticSolidTumors #Cancer #Immunotherapy #ChronicHepatitisDelta #MedAI #PatientsAreWaiting  vir.bio Download the transcript here  

Marianne De Backer is the CEO of Vir Biotechnology, a company developing treatments that harness the power of the immune system to fight serious infectious diseases and cancer. Vir Biotechnology's current clinical trials include a registrational program in chronic hepatitis delta, a rare, often fatal liver disease, as well as two Phase 1 trials of PRO-XTEN™ dual-masked T-cell engagers (TCEs), one targeting HER-2 and the other targeting PSMA, each in heavily pre-treated cancer patients. TCEs have shown tremendous potential but have been limited due to toxicity challenges. The PRO-XTEN™ technology keeps the TCEs masked until they reach the tumor microenvironment, potentially mitigating the toxicity of TCEs and allowing them to unleash their tremendous potential to destroy cancer cells.  Marianne explains, “Vir Biotechnology is an immunology company, and that means that we are really developing treatments that take advantage of the power of basically the patient's own immune system to fight a variety of diseases. We have actually four clinical-stage programs in infectious disease and oncology, and a number of preclinical programs as well. And our most advanced program is to treat chronic hepatitis delta. That is actually a disease caused by a tiny virus, but it's causing liver cancer and is often fatal.” “We have recently initiated our registrational phase 3 program. It's called ECLIPSE. We had previously shown some very compelling data with one of our regimens for treating this disease. We're really excited about progressing that program. And the rest of our clinical pipeline includes a series of so-called PRO-XTEN™ masked T-cell engagers, or in short, TCEs, for the treatment of metastatic solid tumors.”   Vir Biotechnology has exclusive rights to the PRO-XTEN™ masking platform for oncology and infectious disease. PRO-XTEN™ is a trademark of Amunix Pharmaceuticals, Inc. a Sanofi company. #VirBiotechnology #MaskedTCellEngagers #TCellEngagers #SolidTumors #MetastaticSolidTumors #Cancer #Immunotherapy #ChronicHepatitisDelta #MedAI #PatientsAreWaiting  vir.bio Listen to the podcast here  

What happens when an entrepreneur turns their biggest fear—asking for money—into their secret weapon for success? In this episode of The Angel Next Door Podcast, host Marcia Dawood sits down with Maria Springer, founder of Capital Department, to discuss how founders can overcome fundraising anxiety and unlock new paths to capital.Maria's journey began in the social enterprise world of East Africa, where she quickly learned that mastering fundraising was vital to making an impact. Her hard-won expertise now powers Capital Department, a firm that has helped startups secure over $200 million, with a special emphasis on fueling growth through innovative community rounds and crowdfunding.This episode is essential listening for startup founders and investors alike. Maria and Marcia dive into how narrative and organization are key to successful fundraising, the evolving landscape of crowdfunding, and why engaging your community is more powerful than ever. If you want practical fundraising advice and insider stories—like how Pirouette outperformed Substack with a record-setting raise—this conversation is packed with takeaways you won't want to miss. To get the latest from Maria Springer, you can follow her below!https://www.linkedin.com/in/mariaspringer/https://www.capitaldept.com/ Sign up for Marcia's newsletter to receive tips and the latest on Angel Investing!Website: www.marciadawood.comLearn more about the documentary Show Her the Money: www.showherthemoneymovie.comAnd don't forget to follow us wherever you are!Apple Podcasts: https://pod.link/1586445642.appleSpotify: https://pod.link/1586445642.spotifyLinkedIn: https://www.linkedin.com/company/angel-next-door-podcast/Instagram: https://www.instagram.com/theangelnextdoorpodcast/TikTok: https://www.tiktok.com/@marciadawood

Synopsis: What do courtroom litigation, computational biology, and fibrosis drug development have in common? In this episode of Biotech 2050, host Alok Tayi speaks with Ahmed Mousa, CEO of Vicore Pharma, to explore his unconventional journey from biotech law to the C-suite. Ahmed shares how Vicore is advancing a first-in-class therapy targeting the angiotensin II type 2 receptor to treat idiopathic pulmonary fibrosis (IPF)—a devastating disease with limited options and poor survival. The conversation dives into how AI is reshaping drug discovery, the promise of precision in early-stage candidate design, and the regulatory and data challenges biotech must overcome. Ahmed also reflects on leading a Swedish-listed biotech as an American CEO, and how a patient-first mission continues to fuel bold innovation across continents. Biography: Ahmed Mousa is the Chief Executive Officer of Vicore Pharma (VICO.ST), where he leads the company's mission to advance angiotensin II type 2 receptor agonists for the treatment of idiopathic pulmonary fibrosis and other serious diseases. Under his leadership, Vicore continues to expand its clinical pipeline and global presence in respiratory and fibrotic diseases. Previously, Ahmed served as Senior Vice President, Chief Business Officer, and General Counsel at Pieris Pharmaceuticals (PIRS). In this role, he was the site head for the company's Boston office and oversaw business development, portfolio strategy, centralized project leadership, and quality assurance. He also led Pieris' legal and intellectual property functions, including licensing, corporate governance, and management of the company's global patent portfolio. Before joining Pieris, Ahmed was an attorney at Covington & Burling LLP, where he advised pharmaceutical and biotechnology companies on a range of regulatory and intellectual property matters. He also served as a law clerk for the U.S. Court of Appeals for the Third Circuit and began his legal career as an IP associate at Kirkland & Ellis LLP. Ahmed holds dual undergraduate degrees in Molecular Biology and Government from Cornell University, a Master's in Biotechnology from Johns Hopkins University, and a J.D. with honors from Georgetown Law, where he was Editor-in-Chief of the Georgetown Journal of International Law.

Check out the TIES Sales Showdown at www.tx.ag/TIESVisit The Sales Lab at https://thesaleslab.org and check out all our guests' recommended readings at https://thesaleslab.org/reading-listTo listen to The Sales Lab Podcast on your favorite apps, visit https://thesaleslab.simplecast.com/ and select your preferred method of listening.Connect with us on Facebook at https://www.facebook.com/saleslabpodcastConnect with us on Linkedin at https://www.linkedin.com/company/thesaleslabSubscribe to The Sales Lab channel on YouTube at  https://www.youtube.com/channel/UCp703YWbD3-KO73NXUTBI-Q 

The gaps in women's healthcare can be addressed by the Gen Z listeners of this podcast! A professional polymath, Michal Morrison has spent her career bridging the past and present, business and impact. Holding degrees in History and English and a graduate degree in Theology, her academic foundation launched her into 10 years in archaeological and historical research across the Middle East and Mediterranean. She has worked for universities, environmental agencies, and a royal family on heritage protection projects and field research in Greece, Italy, the United Arab Emirates, Turkey, Ireland, and the Americas. A life-changing accident served as a catalyst for a significant career change, and in 2020 Michal founded her eponymous skincare company, Michal Morrison Inc., where she is proud to partner with global leaders from the fields of biotechnology, longevity, and beauty. Michal Morrison is an award-winning biomimetic skincare brand featuring a patented biotech breakthrough based in 25 years of research in regenerative medicine and stem cell science. As a survivor of a Traumatic Brain Injury, Michal believes that businesses should be catalysts for social change. She is dedicated to not only driving scientific innovation in the beauty industry, but to building a sustainably-minded brand that prioritizes accessibility. She launched her brand's social impact initiative, where they have partnered with One Mind, The Trevor Project, and the COPE Program in support of health equity within Indigenous communities. In episode 587 of the Fraternity Foodie Podcast, we find out why Michal chose Texas A&M for her undergraduate experience, how her curiosity evolved into archaeological work, what are the unexpected lessons she learned from her time in international heritage work, how a Traumatic Brain Injury changed her career path, how to adapt with purpose, why she took the leap into biotech and beauty, what has been the most rewarding part of being a woman entrepreneur, how her company integrates purpose with profit, gaps in women's healthcare that Gen Z can address, and common fears or hurdles that young entrepreneurs face. Two books Michal recommended: "Raise Capital On Your Own Terms" and "Leap Frog". If they students are experiencing anxiety around life decisions, pick up "Don't Believe Everything You Think". It's been invaluable to Michal in learning how to have more control over her own occasional existential spirals and managing the 'what ifs' of life.

Latt Mansor explores the multifaceted role of ketones, particularly their influence on brain health, fertility, memory, and focus. The re-release of an episode from 2023 delves into their impact on serotonin receptors, blood glucose regulation, and weight management. Mansor also highlights the potential therapeutic benefits of ketones for conditions such as sleep disturbances, infertility, depression, and Alzheimer's. If you want a balanced approach to health discussions, where scientific understanding encourages expanded knowledge and experience rather than limitations, this is the episode for you. To view full show notes, more information on our guests, resources mentioned in the episode, discount codes, transcripts, and more, visit https://drmindypelz.com/ep296 Dr. Latt Mansor holds a Ph.D. in Physiology, Anatomy and Genetics from the University of Oxford, where his research focused on the metabolism of type 2 diabetic heart in hypoxia. He also holds an M.A. (Columbia University) and a B.Sc. (Hons) (University of Nottingham) in Biotechnology. He is a world expert in physiology and metabolism and consults with elite sports, military, clinical and research organizations. Check out our fasting membership at resetacademy.drmindypelz.com. Please note our medical disclaimer.

Go to https://cozyearth.com and use code HUMANHR for 40% off their best-selling sheets, pajamas, towels, and more. And if you get a post-purchase survey? Let them know you heard about Cozy Earth right here.In this episode, Traci Chernoff interviews Steven Swan, CEO of the Swan Group Executive Search Firm, discussing the evolving landscape of recruiting, particularly the influence of AI. They explore the balance between speed and quality in recruitment, the importance of human connection, and the advantages of external recruiting. Steven shares insights on crafting effective resumes and the purpose behind his podcast, emphasizing the need for emotional intelligence in decision-making during job changes.Chapters00:00 Introduction to Steve Swan and His Journey03:04 The Impact of AI on Recruiting06:02 Quality vs. Speed in Recruitment09:06 The Role of Human Connection in Recruitment12:00 The Advantages of External Recruiting15:11 Crafting Effective Resumes and LinkedIn Profiles17:56 The Purpose Behind the Podcast20:58 Advice for Aspiring Recruiters23:59 Navigating Job Changes and Emotional IntelligenceWe hope you enjoyed this episode with Steven Swan. If you found our discussion insightful, we'd like you to take a moment to rate our podcast. Your feedback helps us grow and reach more listeners who are passionate about these topics. You can also leave a review and tell us what you loved or what you'd like to hear more of - we're all ears!Don't forget to rate, review, and subscribe! Plus, leave a comment if you're catching this episode on Spotify or YouTube.About Our Guest: Steve Swan stands at the helm of The Swan Group Executive Search Firm as its CEO and Principal, carving a niche in the Pharma/Biotech industries with a keen focus on IT. His fervor for industry insights and a knack for bridging the gap between top professionals and industry demands have been instrumental in elevating organizations and propelling careers forward.Steve helms the popular podcast “Biotech Bytes.” A show that offers a stage for dialogue with IT luminaries in Biotechnology and Pharmaceuticals. Each episode delves into the minds of industry trailblazers, unpacking best practices and strategies that shape the life sciences realm. Steve's academic background in Psychology has helped him to understand both parties' deeper needs and motivations which is paramount to delivering candidates who become long-term  assets to the company. At the core of The Swan Group's philosophy is the ability to discern and fulfill what success means for both candidates and clients. Outside of work, Steve, once an avid mountain bike racer, has reignited his passion for cycling and aspires to traverse the U.S. on  two wheels. He lives in New Jersey with his wife and two daughters.Connect with Steven Swan here:LinkedIn: https://www.linkedin.com/in/swangroup/ Website: https://swangroup.net/ Connect with Traci here: ⁠https://linktr.ee/HRTraci⁠Disclaimer: Thoughts, opinions, and statements made on this podcast are not a reflection of the thoughts, opinions, and statements of the Company by whom Traci Chernoff is actively employed.Please note that this episode may contain paid endorsements and advertisements for products or services. Individuals on the show may have a direct or indirect financial interest in products or services referred to in this episode.

We love to hear from our listeners. Send us a message. This week's episode is one from the road, recorded in front of a live audience in Boston's Seaport neighborhood during the BIO conference (special thanks to MasterControl for making it happen). Amber Salzman, Ph.D., CEO of Epicrispr Biotechnologies (aka 'Epic Bio') explains how epigenetic editing is revolutionizing genetic medicine by controlling gene expression, without cutting DNA like traditional CRISPR technologies. Amber talks about FSHD, a progressive muscular dystrophy, how the company raised $68 million in Series B funding despite challenging market conditions, her partnership with Springbok Analytics for AI analysis of MRI images, working with a CDMO to manufacture a new treatment modality, and navigating the FDA during a time of disruption. Access this and hundreds of episodes of the Business of Biotech videocast under the Business of Biotech tab at lifescienceleader.com. Subscribe to our monthly Business of Biotech newsletter. Get in touch with guest and topic suggestions: ben.comer@lifescienceleader.comFind Ben Comer on LinkedIn: https://www.linkedin.com/in/bencomer/

What if the next virus isn't natural, but deliberately engineered and used as a weapon? As geopolitical tensions rise and biological threats become more complex, health security and life sciences are emerging as critical pillars of national defense.In the special edition episode from our new series, “The Ripple Effect: Investing in Life Sciences”, host Dan Riskin is joined by two leading voices at the intersection of biotechnology and defense: Dawn Meyerriecks, former CIA Deputy Director for Science and Technology and current member of the National Security Commission on Emerging Biotechnology, and Jason Kelly, co-founder and CEO of Ginkgo Bioworks. Together, they explore the dual-use nature of biotechnology and the urgent need for international oversight, genetic attribution standards, and robust viral surveillance. From pandemic preparedness and fragile supply chains to AI-driven lab automation and airport biosurveillance, their conversation highlights how life science innovation strengthens national resilience and strategic defense.This timely conversation follows the June 25th, 2025 Hague Summit Declaration, where NATO allies pledged to invest 5% of GDP in defense by 2035—including up to 1.5% on resilience and innovation to safeguard critical infrastructure, civil preparedness, networks, and the defense industrial base. This limited series, produced by GZERO's Blue Circle Studios in partnership with Novartis, examines how life science innovation plays a vital role in fulfilling that commitment. Subscribe to “The Ripple Effect: Investing in Life Sciences” series on your preferred podcast platform.Look for the next episode of the GZERO World with Ian Bremmer podcast when we kick off our eighth season on July 5, 2025.Host: Dan RiskinGuests: Jason Kelly, Dawn Meyerriecks Subscribe to the GZERO World with Ian Bremmer Podcast on Apple Podcasts, Spotify, or your preferred podcast platform, to receive new episodes as soon as they're published.

durée : 00:58:04 - Avec philosophie - par : Géraldine Muhlmann, Nassim El Kabli - On croit savoir ce que sont les nouvelles technologies NBIC (Nanotechnologies, Biotechnologies, sciences de l'Information et de la Cognition). On entend là-dedans des progrès possibles, pour la médecine par exemple, mais on se doute aussi qu'il y a des risques. Se posent donc des enjeux éthiques. - réalisation : Nicolas Berger - invités : Vanessa Nurock Philosophe, maître de conférences en théorie politique et éthique à l'université Paris 8; François Berger Neuroscientifique, directeur de l'unité INSERM BrainTech Lab, qui développe les technologies innovantes pour comprendre et traiter les pathologies cérébrales.

In celebration of Pride Month, we're sharing two stories about coming out with the help of science. Part 1: After years of struggling with their gender identity, Parker Sublette finds inspiration in marine life. Part 2: Bullied as a kid for the sound of his voice, Garret Glinka begins to reclaim his confidence thanks to biology class. Parker Sublette is a comedian and speculative fiction writer living in Brooklyn, New York. She can usually be found scrambling around the city looking for any stage that will have her, or at home with her roommates and their two cats. Parker also sometimes hosts an open-mic in Bushwick, you can find her @parks_jokez on instagram. Garret Glinka: I wear two hats: one as a businessman with half a Master's in Business, and the other as a scientist, with another half in Biotechnology and Genomics, complemented by a Bachelor's in Biological Sciences. My background allows me to bridge the administrative and scientific worlds. Over the past six years, I've honed my expertise as a laboratory professional in both corporate and academic settings, helping operate and set up five laboratories domestically/internationally. I've been a technician, team leader, supervisor, and lab manager. As a member of the queer community, I bring kindness, authenticity, vulnerability, and positive influence to my leadership style. Now at Columbia University's Neuroscience Institute, I manage two labs, lead the Gender and Inclusion Mentoring Program, and coordinate the Lab Liaison Group, ensuring communication across the institute's departments and other lab managers. When I'm not dissecting Drosophila in New York City, or out to eat with Jersey City friends, I retreat to my family's farm in central New Jersey. There you'll find me tending to our goats and chickens, inspecting the crops, or racing dirt bikes with my three-year-old nephew, Jay. My life is a dynamic blend of science, leadership, community, and family, each enriching the other in unexpected ways. Learn more about your ad choices. Visit megaphone.fm/adchoicesSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In celebration of Pride Month, we're sharing two stories about coming out with the help of science. Part 1: After years of struggling with their gender identity, Parker Sublette finds inspiration in marine life. Part 2: Bullied as a kid for the sound of his voice, Garret Glinka begins to reclaim his confidence thanks to biology class. Parker Sublette is a comedian and speculative fiction writer living in Brooklyn, New York. She can usually be found scrambling around the city looking for any stage that will have her, or at home with her roommates and their two cats. Parker also sometimes hosts an open-mic in Bushwick, you can find her @parks_jokez on instagram. Garret Glinka: I wear two hats: one as a businessman with half a Master's in Business, and the other as a scientist, with another half in Biotechnology and Genomics, complemented by a Bachelor's in Biological Sciences. My background allows me to bridge the administrative and scientific worlds. Over the past six years, I've honed my expertise as a laboratory professional in both corporate and academic settings, helping operate and set up five laboratories domestically/internationally. I've been a technician, team leader, supervisor, and lab manager. As a member of the queer community, I bring kindness, authenticity, vulnerability, and positive influence to my leadership style. Now at Columbia University's Neuroscience Institute, I manage two labs, lead the Gender and Inclusion Mentoring Program, and coordinate the Lab Liaison Group, ensuring communication across the institute's departments and other lab managers. When I'm not dissecting Drosophila in New York City, or out to eat with Jersey City friends, I retreat to my family's farm in central New Jersey. There you'll find me tending to our goats and chickens, inspecting the crops, or racing dirt bikes with my three-year-old nephew, Jay. My life is a dynamic blend of science, leadership, community, and family, each enriching the other in unexpected ways. Learn more about your ad choices. Visit megaphone.fm/adchoices